539 related articles for article (PubMed ID: 31116395)
21. Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
Takahashi K; Miura K; Shima Y; Okabe K; Ikuta A; Taguchi Y; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
J Cardiol; 2022 Aug; 80(2):155-161. PubMed ID: 35282943
[TBL] [Abstract][Full Text] [Related]
22. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
Garg A; Rout A; Sharma A; Sargsyan D; Beavers T; Tantry U; Gurbel P; Rao SV; Kostis JB; Cohen M
Prog Cardiovasc Dis; 2020; 63(3):243-248. PubMed ID: 32247786
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.
Carrié D; Menown I; Oldroyd K; Copt S; Talwar S; Maillard L; Morice MC; Teik LS; Lang I; Urban P
JACC Cardiovasc Interv; 2017 Aug; 10(16):1633-1642. PubMed ID: 28838473
[TBL] [Abstract][Full Text] [Related]
25. Ischemic Versus Bleeding Outcomes After Percutaneous Coronary Interventions in Patients With High Bleeding Risk.
Gajanana D; Rogers T; Weintraub WS; Kolm P; Iantorno M; Khalid N; Chen Y; Shlofmitz E; Khan JM; Musallam A; Ben-Dor I; Satler LF; Zhang C; Torguson R; Waksman R
Am J Cardiol; 2020 Jun; 125(11):1631-1637. PubMed ID: 32273057
[TBL] [Abstract][Full Text] [Related]
26. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI.
Chichareon P; Modolo R; Kawashima H; Takahashi K; Kogame N; Chang CC; Tomaniak M; Ono M; Walsh S; Suryapranata H; Cotton J; Koning R; Akin I; Kukreja N; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
JACC Cardiovasc Interv; 2020 Mar; 13(5):634-646. PubMed ID: 32139222
[TBL] [Abstract][Full Text] [Related]
27. Frailty and Bleeding After Percutaneous Coronary Intervention.
Kanenawa K; Yamaji K; Tashiro H; Morimoto T; Hiromasa T; Hayashi M; Hiramori S; Tomoi Y; Kuramitsu S; Domei T; Hyodo M; Ando K; Kimura T
Am J Cardiol; 2021 Jun; 148():22-29. PubMed ID: 33667444
[TBL] [Abstract][Full Text] [Related]
28. Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Chahine A; Gwinn M; Ahmed S; Hassan M; Bachuwa G; Bhatt DL
Cardiovasc Revasc Med; 2019 Sep; 20(9):744-751. PubMed ID: 30446398
[TBL] [Abstract][Full Text] [Related]
29. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
30. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.
Capodanno D; Morice MC; Angiolillo DJ; Bhatt DL; Byrne RA; Colleran R; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J; Farb A; Gibson CM; Gregson J; Haude M; James SK; Kim HS; Kimura T; Konishi A; Leon MB; Magee PFA; Mitsutake Y; Mylotte D; Pocock SJ; Rao SV; Spitzer E; Stockbridge N; Valgimigli M; Varenne O; Windhovel U; Krucoff MW; Urban P; Mehran R
J Am Coll Cardiol; 2020 Sep; 76(12):1468-1483. PubMed ID: 32943165
[TBL] [Abstract][Full Text] [Related]
31. Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
Int J Cardiol; 2021 Feb; 325():121-126. PubMed ID: 33053391
[TBL] [Abstract][Full Text] [Related]
32. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
[TBL] [Abstract][Full Text] [Related]
33. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes (SMART-DATE) prospective multicenter randomized trial.
Lee JM; Cho DK; Hahn JY; Song YB; Park TK; Oh JH; Lee JB; Doh JH; Kim SH; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC
Am Heart J; 2016 Dec; 182():1-8. PubMed ID: 27914488
[TBL] [Abstract][Full Text] [Related]
34. Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.
Baber U; Dangas G; Chandrasekhar J; Sartori S; Steg PG; Cohen DJ; Giustino G; Ariti C; Witzenbichler B; Henry TD; Kini AS; Krucoff MW; Gibson CM; Chieffo A; Moliterno DJ; Weisz G; Colombo A; Pocock S; Mehran R
JACC Cardiovasc Interv; 2016 Jul; 9(13):1349-57. PubMed ID: 27388822
[TBL] [Abstract][Full Text] [Related]
35. Predictive Ability of Academic Research Consortium for High Bleeding Risk Criteria in ST-Elevation Myocardial Infarction Patients Undergoing Primary Coronary Intervention.
Fujii T; Ikari Y
Circ J; 2021 Jan; 85(2):159-165. PubMed ID: 33177266
[TBL] [Abstract][Full Text] [Related]
36. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
Costa F; Van Klaveren D; Feres F; James S; Räber L; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M;
J Am Coll Cardiol; 2019 Feb; 73(7):741-754. PubMed ID: 30784667
[TBL] [Abstract][Full Text] [Related]
37. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
[TBL] [Abstract][Full Text] [Related]
38. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3.
Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
[TBL] [Abstract][Full Text] [Related]
39. Academic Research Consortium for High Bleeding Risk Definitions for Early, Late, and Very Late Bleeding Events.
Miura K; Shima Y; Okabe K; Taguchi Y; Ikuta A; Takahashi K; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
Circ J; 2021 May; 85(6):797-805. PubMed ID: 33853992
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Incidence and Details of Bleeding Events After Everolimus-Eluting Stent Implantation - 7-8-Year Outcomes.
Miura K; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K
Circ J; 2019 Oct; 83(11):2242-2249. PubMed ID: 31495801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
